Work

Efficacy and safety of nivolumab monotherapy in patients with metastatic urothelial cancer (mUC) who have received prior treatment: Results from the phase II CheckMate 275 study

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw435.24

Authors: M.D. Galsky, M. Retz, A.O. Siefker-Radtke, A. Baron, A. Necchi, J. Bedke, E.R. Plimack, D. Vaena, M.-O. Grimm, S. Bracarda, J. Arranz Arija, S.K. Pal, C. Ohyama, A. Saci, A. Lambert, S. Krishnan, A. Azrilevich, P. Sharma

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, TUM Klinikum, The University of Texas MD Anderson Cancer Center, California Pacific Medical Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Universitätsklinikum Tübingen, Fox Chase Cancer Center, University of Iowa, Jena University Hospital, Ospedale San Donato, Hospital General Universitario Gregorio Marañón, City Of Hope National Medical Center, City of Hope, Hirosaki University, Bristol-Myers Squibb (United States)

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Merck

OpenAlex ID: W2587806815

FWCI: 8.481

Cites:

Cited by: 28

Related to: 10